SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11,350.60 |
| Enterprise Value ($M) | 12,380.31 |
| Book Value ($M) | 1,221.07 |
| Book Value / Share | 12.78 |
| Price / Book | 9.30 |
| NCAV ($M) | 306.51 |
| NCAV / Share | 3.21 |
| Price / NCAV | 37.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.03 |
| Current Ratio | 3.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,685.37 |
| Assets | 3,599.93 |
| Liabilities | 2,378.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 4.60 | -18.47 | |
| 13G/A | Capital International Investors | 6.70 | 34.21 | |
| 13G/A | BlackRock, Inc. | 10.70 | 61.55 | |
| 13G/A | Vanguard Group Inc | 9.42 | 9.75 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 129,478 | 448,674 | 28.86 | |
| 423,455 | 1,135,021 | 37.31 | |
| 357,347 | 1,267,907 | 28.18 | |
| 218,696 | 648,487 | 33.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SLRN – Acelyrin, Inc. | SNDX – Syndax Pharmaceuticals, Inc. |
| SPRO – Spero Therapeutics, Inc. | SRRK – Scholar Rock Holding Corporation |
| STOK – Stoke Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io